Response: how PGS/PGT-A laboratories succeeded in losing all credibility

Affiliations

¹ Cytogenetics and Medical Genetics Unit, TOMA Advanced Biomedical Assays S.p.A., Busto Arsizio VA, Italy. Electronic address: fgrati@tomalab.com.
² Cytogenetics and Medical Genetics Unit, TOMA Advanced Biomedical Assays S.p.A., Busto Arsizio VA, Italy.
³ Prenatal Genetic Diagnosis Unit, Genetic Institute, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Comment

Francesca Romana Grati et al. Reprod Biomed Online. 2018 Aug.

. 2018 Aug;37(2):246.

doi: 10.1016/j.rbmo.2018.06.020.

¹ Cytogenetics and Medical Genetics Unit, TOMA Advanced Biomedical Assays S.p.A., Busto Arsizio VA, Italy. Electronic address: fgrati@tomalab.com.
² Cytogenetics and Medical Genetics Unit, TOMA Advanced Biomedical Assays S.p.A., Busto Arsizio VA, Italy.
³ Prenatal Genetic Diagnosis Unit, Genetic Institute, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

No abstract available

Comment on

An evidence-based scoring system for prioritizing mosaic aneuploid embryos following preimplantation genetic screening.
Grati FR, Gallazzi G, Branca L, Maggi F, Simoni G, Yaron Y. Grati FR, et al. Reprod Biomed Online. 2018 Apr;36(4):442-449. doi: 10.1016/j.rbmo.2018.01.005. Epub 2018 Feb 9. Reprod Biomed Online. 2018. PMID: 29433970
How PGS/PGT-A laboratories succeeded in losing all credibility.
Gleicher N, Kushnir VA, Barad DH. Gleicher N, et al. Reprod Biomed Online. 2018 Aug;37(2):242-245. doi: 10.1016/j.rbmo.2018.06.019. Reprod Biomed Online. 2018. PMID: 30075841 No abstract available.